Daigdigan, Ronald L.
HRN: 28-62-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
CEFTRIAXONE 1G (VIAL)
04/12/2026
04/18/2026
IV
2g
OD
Intraabdominal Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: